| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | SK Bioscience, Gates MRI Partner to Advance RSV Preventive mAb Candidate | ||
| Mo | SEQSTER, Praxis Extend Partnership | ||
| Mo | Freudenberg Medical Launches LUBRITEQ High-Performance Hydrophilic Coating | ||
| Mo | Piramal Pharma Solutions Introduces Tablet-in-Capsule Drug Delivery System | ||
| Mo | J&J 4Q Results | ||
| Mo | Alterome Therapeutics Appoints Leonardo Faoro as New CMO | ||
| Mo | Takeda Reshapes Leadership, Creates New Units Ahead of Fiscal 2026 | ||
| Mo | Frontage Labs Expands Early Phase Clinical Capabilities | ||
| Mo | Quotient Therapeutics Appoints Susan Keefe as CFO | ||
| 30.01. | Lilly to Build New Pennsylvania Manufacturing Facility | ||
| 30.01. | Ardena Completes Divestment of Sweden Drug Substance Site to Nanologica | ||
| 30.01. | Merz Therapeutics Taps Dan Staner as President, Region Europe | ||
| 30.01. | Libris Innovations Taps Ramani Veranasi as CEO | ||
| 29.01. | New Veeva Application Eliminates Paper, Streamlines Clinical Trial Data Flow | ||
| 29.01. | Vetter to Build New Production Facility in Germany | ||
| 29.01. | Opentrons Formally Announces James Atwood as CEO | ||
| 29.01. | WuXi Biologics, Sinorda Biomedicine Partner to Advance SND006 | ||
| 29.01. | IQVIA to Share its DaaS+ Platform in Boehringer Ingelheim Collaboration | ||
| 29.01. | Halozyme Acquires Surf Bio for up to $400M | ||
| 29.01. | Satellos Bioscience Taps Antoinette Paone as Chief Development Officer | ||
| 28.01. | Elysium Therapeutics Raises $7.5M to Advance Opioid Overdose Reversal Tech | ||
| 28.01. | Cellares Raises $257M to Industrialize Global Cell Therapy Manufacturing | ||
| 28.01. | Fujirebio Unveils CSF Assay to Assist Alzheimer's Research | ||
| 28.01. | Veranova Taps Former Alcami Exec as Chief Quality Officer | ||
| 28.01. | Halo Pharma Becomes Stand-Alone CDMO Business |